US FDA ‘Punt’ On Hemp Rulemaking Frustrates, Confuses Supplement Industry

Industry trade groups say FDA decision against starting rulemaking for lawful use of hemp ingredients is not only overdue but failed to clear the air for businesses making or using the ingredients.

• Source: Shutterstock

US dietary supplement industry trade groups didn’t welcome the Food and Drug Administration’s decision against starting a rulemaking for lawful use of hemp ingredients but dismissed it as overdue while still failing to clear the air for businesses making or using the ingredients.

Supplements containing cannabidiol and other hemp ingredients remain available in the US without regulatory acknowledgement as the FDA opts to asks Congress to authorize establishing a process for allowing

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Cannabis/CBD

More from Ingredients & Safety